NEW YORK, March 20 – Celera Genomics said Tuesday it had appointed Lothar Krinke vice president, business development and strategic planning.

In his new position Krinke, who previously worked at management consulting firm A.T. Kearney, will be responsible for overseeing potential mergers and acquisitions as well as expanding the company’s information business.

A company spokesperson was not immediately available to comment on the company’s current business strategy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.